Skip to main content

Advertisement

Log in

Capsaicin inhibits benzo(a)pyrene-induced lung carcinogenesis in an in vivo mouse model

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective

Lung cancer is a serious health problem in most developed countries and its incidence rate is profusely increasing. Capsaicin, a component of red chilli and red pepper has been studied widely for its chemopreventive properties. The aim of the present study is to explore the anti-tumor activity of capsaicin against benzo(a)pyrene-induced lung tumorigenesis in Swiss albino mice.

Materials and methods

Benzo(a)pyrene was administered orally (50 mg/kg body weight) to induce lung cancer in Swiss albino mice. Hematological study (hemoglobin content, RBC, WBC count and differential count), histochemical analysis of mast cells and Western blot analysis of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), cyclooxygenase-2 (COX-2) and nuclear factor-kappa B (NF-κB) were carried out.

Results

Hematological parameters and the histochemical analysis of mast cells showed abnormal changes, and the immunoblotting analysis revealed increased protein expression of TNF-α, IL-6, COX-2 and NF-κB in lung cancer-challenged mice administered with benzo(a)pyrene. Capsaicin (10 mg/kg body weight) supplementation to lung cancer bearing mice considerably prevented all the above abnormalities.

Conclusion

The results of the present study indicate the protective effect of capsaicin against benzo(a)pyrene-induced lung carcinogenesis in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Magesh V, Jayapal PV, Selvendiran K, Ekambaram G, Sakthisekaran D. Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol Cell Biochem. 2006;287:127–35.

    Article  PubMed  CAS  Google Scholar 

  2. Stephen S, Pramod Upadhaya, Mingyao Wang, Robin Bliss L, Edward Mcintee J, Patrick Kenney MJ. Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine and myo-inositol, individually and in combination. Carcinogenesis. 2002;29:1455–61.

    Google Scholar 

  3. Hans peter W, Deuter M, Imilda E. Chemoprevention of tobacco smoke induced lung carcinogenesis in mice. Carcinogenesis 2000; 21:977–982.

    Google Scholar 

  4. Anto RJ, Mukhopadyah A, Denning K, Aggarwal BB. Curcumin induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis. 2002;23:143–50.

    Article  PubMed  CAS  Google Scholar 

  5. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991;43(2):143–201.

    PubMed  CAS  Google Scholar 

  6. Holzer P. The pharmacological challenge to the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol. 2008;155(8):1145–62.

    Article  PubMed  CAS  Google Scholar 

  7. Pinter E, Helyes Z, Szolcsányi J. Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther. 2006;112(2):440–56.

    Article  PubMed  CAS  Google Scholar 

  8. Modly CE, Das M, Don PS, Marcelo CS, Mukhtar H, Bickers DR. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes. Drug Metab Dispos. 1986;14:413–6.

    PubMed  CAS  Google Scholar 

  9. Zhang Z, Hamilton SM, Stewart C, Strother A, Teel RW. Inhibition of liver microsomal cytochrome P-450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res. 1993;13:2341–6.

    PubMed  CAS  Google Scholar 

  10. Teel RW, Zhang Z, Uynh H, Hamilton SM. Effects of capsaicin on the metabolic activation of heterocyclic amines and on cytochrome P450 1A2 activity in hamster liver microsomes. Proc Am Assoc Cancer Res. 1997;38:363.

    Google Scholar 

  11. De AK, Ghosh JJ. Capsaicin pretreatment protects free radical induced rat lung damage on exposure to gaseous chemical lung irritants. Phytother Res. 1993;7:87–9.

    Article  CAS  Google Scholar 

  12. Anandakumar P, Kamaraj S, Jagan S, Ramakrishnan G, Naveenkumar C, Asokkumar S, Devaki T. Capsaicin alleviates the imbalance in xenobiotic metabolizing enzymes and tumor markers during experimental lung tumorigenesis. Mol Cell Biochem. 2009;331(1–2):135–43.

    Article  PubMed  CAS  Google Scholar 

  13. Anandakumar P, Kamaraj S, Jagan S, Ramakrishnan G, Devaki T. Effect of capsaicin on glucose metabolism studied in experimental lung carcinogenesis. Nat Prod Res. 2009;23(8):763–74.

    Article  PubMed  CAS  Google Scholar 

  14. Anandakumar P, Kamaraj S, Jagan S, Ramakrishnan G, Devaki T. Chemopreventive task of capsaicin against benzo(a)pyrene induced lung cancer in Swiss albino mice. Basic Clin Pharmacol Toxicol. 2009;104(5):360–5.

    Article  PubMed  CAS  Google Scholar 

  15. Dacie JV, Lewis SM. Practical haematology. 7th ed. ELBS with Churchill Living stone: England; 1991. pp 37–85.

  16. D’Armour FE, Blood FR, Belden DA. The manual for laboratory works in mammalian physiology. 3rd ed. The University of Chicago Press: Illinois, Chicago; 1965.

  17. Wintrobe MM, Lee GR, Boggs DR, Bithel TC, Athens JW, Foerster J. Clinical Hematology. 5th ed. Les & Febiger: Philadelphia; 1961.

  18. Ranieri G, Labriola A, Achille G, Florio G, Zito AF, Grammatica L, et al. Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int J Oncol. 2002;21(6):1317–23.

    PubMed  CAS  Google Scholar 

  19. Ramakrishnan G, Elinos-Baez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T. Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma. Mol Cell Biochem. 2008;313:53–61.

    Article  PubMed  CAS  Google Scholar 

  20. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999;91:1616–34.

    Article  PubMed  CAS  Google Scholar 

  21. Brown JM. The hypoxic cell: a target for selective cancer therapy—Eighteenth Bruce F Cain memorial award lecture. Cancer Res. 1999;59:5863–70.

    PubMed  CAS  Google Scholar 

  22. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Caner Inst. 2001;93:266–76.

    Article  CAS  Google Scholar 

  23. Gangar SC, Sandhir R, Koul A. Effects of Azadirachta indica on certain hematological parameters during benzo(a)pyrene induced murine forestomach tumorigenesis. Eur Rev Med Pharmacol. 2010;14:1055–72.

    CAS  Google Scholar 

  24. Ariztia EV, Lee CJ, Gogoi R, Fishman DA. The tumor microenvironment: key to early detection. Crit Rev Clin Lab Sci. 2006;43:393–425.

    Article  PubMed  CAS  Google Scholar 

  25. Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004;14:433–9.

    Article  PubMed  CAS  Google Scholar 

  26. Noguchi M, Hiwatashi N, Liu Z, Toyota T. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut. 1998;43:203–9.

    Article  PubMed  CAS  Google Scholar 

  27. Ben-Baruch A. Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res. 2003;5:31–6.

    Article  PubMed  CAS  Google Scholar 

  28. Tselepis C, Perry I, Dawson C, Hardy R, Darnton SJ, McConkey C, Stuart RC, Wright N, Harrison R, Jankowski JA. Tumour necrosis factor-a in Barrett’s oesophagus: a potential novel mechanism of action. Oncogene. 2002;21:6071–81.

    Article  PubMed  CAS  Google Scholar 

  29. Rose-John S, Schooltink H. Cytokines are a therapeutic target for the prevention of inflammation-induced cancers. Recent Results Cancer Res. 2007;174:57–66.

    Article  PubMed  CAS  Google Scholar 

  30. Kai H, Kitadai Y, Kodama M, Cho S, Kuroda T, Ito M, Tanaka S, Ohmoto Y, Chayama K. Involvement of proinflammatory cytokines IL-1b and IL-6 in progression of human gastric carcinoma. Anticancer Res. 2005;25:709–13.

    PubMed  CAS  Google Scholar 

  31. Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett. 2000;151:31–8.

    Article  PubMed  CAS  Google Scholar 

  32. Chung YC, Chang YF. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol. 2003;83:222–6.

    Article  PubMed  Google Scholar 

  33. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol. 2006;72:1605–21.

    Article  PubMed  CAS  Google Scholar 

  34. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, et al. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancer, specifically in adenocarcinomas. Cancer Res. 1998;58:3761–4.

    PubMed  CAS  Google Scholar 

  35. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 1997;57:1276–80.

    PubMed  CAS  Google Scholar 

  36. Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, Sweeney CJ. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis. 2000;21:139–46.

    Article  PubMed  CAS  Google Scholar 

  37. Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest. 1993;91:2194–206.

    Article  PubMed  CAS  Google Scholar 

  38. Lawrence T. Inflammation and cancer: a failure of resolution? Trends Pharmacol Sci. 2007;28:162–5.

    Article  PubMed  CAS  Google Scholar 

  39. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461–6.

    Article  PubMed  CAS  Google Scholar 

  40. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006;4:221–33.

    Article  PubMed  Google Scholar 

  41. Melendez AJ, Harnett MM, Pushparaj PN, et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med. 2007;13:1211–8.

    Article  Google Scholar 

  42. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 2004;25:235–41.

    Article  PubMed  CAS  Google Scholar 

  43. Tan S-Y, Fan Y, Luo H-S, Shen Z-X, Guo Y, Zhao L-J. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol. 2005;11:1210–4.

    PubMed  Google Scholar 

  44. Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer. 2000;15:2686–92.

    Article  Google Scholar 

Download references

Acknowledgments

First author Anandakumar P wishes to thank Mr. Pandi, Mrs. Padmavathi, Mrs. Kalaivani and Ms. Prabhavathy for their moral support and encouragement throughout the period of study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Devaki.

Additional information

Responsible Editor: Andras Falus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anandakumar, P., Kamaraj, S., Jagan, S. et al. Capsaicin inhibits benzo(a)pyrene-induced lung carcinogenesis in an in vivo mouse model. Inflamm. Res. 61, 1169–1175 (2012). https://doi.org/10.1007/s00011-012-0511-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-012-0511-1

Keywords

Navigation